CAY10583 is primarily used in biochemical research as a selective inhibitor of the enzyme soluble epoxide hydrolase (sEH). This enzyme plays a significant role in the metabolism of epoxy fatty acids, which are involved in various physiological processes, including inflammation, pain, and cardiovascular function. By inhibiting sEH, CAY10583 helps researchers study the effects of increased epoxy fatty acid levels, particularly in models of inflammation and cardiovascular diseases. Its application is crucial for understanding the therapeutic potential of sEH inhibition in conditions such as hypertension, atherosclerosis, and chronic inflammatory disorders. Additionally, it serves as a valuable tool in pharmacological studies aimed at developing novel anti-inflammatory and cardioprotective drugs.